戻る戻るSHANGHAI BIO-HEART BIOLOGICAL TECHNの希薄化EPS (希薄化後1株当たり利益)
年間データ
−2.00
−1.50
−1.00
−0.50
0.00
直近12ヶ月
−0.51
+0.29
+35.74%
2023
−0.80
+0.18
+18.16%
2022
−0.98
+0.81
+45.36%
2021
−1.79
−0.29
−19.09%
2020
−1.50
−1.39
−1.26 K%
半期データ
H2 '21
H1 '22
H2 '22
H1 '23
H2 '23
H1 '24
−0.48
−0.36
−0.24
−0.12
0.00
H1 '24
−0.12
+0.28
+71.11%
H2 '23
−0.40
+0.00
+0.57%
H1 '23
−0.40
+0.07
+15.51%
H2 '22
−0.47
+0.03
+5.62%